RNA micelles enable targeted chemotherapy without immune toxicity
View as a Web Page
News Medical
 
  Oncology Oncology logo  
  The latest oncology news from News Medical  
 Senescent neutrophils promote tumor survival across cancer typesSenescent neutrophils promote tumor survival across cancer types
 
Renowned as first responders to threatening infections, neutrophils also happen to feature prominently in the microenvironment of tumors, where they and other immune cells play opposing and frequently mutable roles in promoting-or resisting-cancer progression.
 
 
 RNA micelles enable targeted chemotherapy without immune toxicityRNA micelles enable targeted chemotherapy without immune toxicity
 
A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or toxicity-related side effects.
 
   PSMA PET/CT scans may predict prostate cancer recurrence, guide treatmentPSMA PET/CT scans may predict prostate cancer recurrence, guide treatment
 
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to predict progression-free survival (PFS) and guide treatment planning in patients with rising prostate-specific antigen (PSA) levels following removal of the prostate.
 
   Mesothelial cells enable rapid invasion and spread of ovarian cancerMesothelial cells enable rapid invasion and spread of ovarian cancer
 
Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen.
 
   Digital twins in precision medicine and drug discoveryDigital twins in precision medicine and drug discovery
 
Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.
 
 Early biomarkers predict infections after breast reconstruction surgery
 
Early biomarkers predict infections after breast reconstruction surgeryIn the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies.
 
 
 Chronic brain compression triggers neuron death through multiple pathways
 
Chronic brain compression triggers neuron death through multiple pathwaysTo think, feel, talk and move, neurons send messages through electrical signals in the brain and spinal cord.
 
 
 Study reveals how inherited genetic abnormalities raise Barrett’s esophagus risk
 
Study reveals how inherited genetic abnormalities raise Barrett’s esophagus riskCase Western Reserve University researchers have made a significant breakthrough in understanding Barrett's esophagus, a precancerous condition that dramatically increases the risk of developing esophageal adenocarcinoma, one of the fastest-spreading and deadliest forms of cancer.
 
 
 Bioadhesive patches target remaining glioblastoma cells after surgery
 
Bioadhesive patches target remaining glioblastoma cells after surgeryGlioblastoma is the most prevalent and aggressive brain tumor. It proliferates very rapidly, is highly invasive, and there is currently no treatment capable of halting its progression or curing it, which means life expectancy after diagnosis is very short.
 
 
 SPT Labtech and Bellbrook Labs introduce high-throughput screening platform for cancer research
 
SPT Labtech and Bellbrook Labs introduce high-throughput screening platform for cancer researchSPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life sciences, and BellBrook Labs, a pioneer in high-throughput screening (HTS) assay tools, today announced a collaboration to advance cancer research.
 
 
 US cancer institute studying ivermectin’s ‘ability to kill cancer cells’
 
The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, according to its top official.
 
 
 Nervous system actively promotes pre-cancerous pancreatic lesions
 
Pancreatic cancer has a lot of nerve. Notoriously tricky to detect, the disease also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation.
 
 
 University of Missouri launches first on-campus radiopharmaceutical clinical trial
 
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU Health Care have launched their first clinical trial using a leading-edge therapy manufactured on campus at the university's research reactor.
 
 
 Dual targeting strategy suppresses pancreatic cancer cell growth
 
A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled "Dual targeting of oncogenic microtubules and mitochondria in PDAC."
 
 
 New nanoparticle separation method boosts biotech and cancer research
 
In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves particle separation and purification.
 
 
 Choroid plexus enlargement in Long COVID signals cognitive risk
 
The increased size of, and lesser blood supply to, a key brain structure in patients with Long COVID tracks with known blood markers of Alzheimer's disease and greater levels of dementia, a new study finds.
 
 
 Niacin shows promise in improving treatment for glioblastoma patients
 
Edward (Ed) Waldner had no idea why he didn't feel well but he knew he didn't feel like himself. At 55-years of age he felt exhausted all the time.
 
 
 AI system reads brain MRIs with high diagnostic accuracy
 
An AI-powered model developed at University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests.
 
 
 Researchers uncover mechanisms of three mismatch repair deficient high-grade glioma subtypes
 
Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas.
 
 
 DNA barcoding can be used to track cancer cells in solid and liquid biopsies
 
Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and treatment strategies.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026